Purchase Order 75N98026P01258

Creagen Inc. was awarded a $80,000 purchase order by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a part of the National Institutes of Health (NIH), to provide services related to a library of bioactive molecules. The contract has a period of performance from July 24, 2023 through September 23, 2023 and utilizes a firm fixed price structure. To be performed in Woburn, Massachusetts, the effort aims to support the NIDDK's research programs through the...

The U.S. National Institute of Child Health and Human Development (NIDDK) awarded a $94,400.00 Firm Fixed Price purchase order contract to Creagen Inc., a small, minority-owned business located in Woburn, Massachusetts. The contract is for the synthesis of chemical compounds, which will support NIDDK's medical research programs. Creagen Inc. is an SBA Certified 8(a) Program Participant and a self-certified small disadvantaged business. The company has significant experience providing specialized...

This is a $66,000.00 firm-fixed-price purchase order awarded by the National Institute on Aging, a civilian agency within the U.S. government, to Creagen Inc., a small business contractor. The contract is for custom antibody-conjugated drug (ADC) services, which are set aside for small business. Creagen Inc. is a minority-owned small disadvantaged business that provides chemistry-based drug discovery services to government agencies such as the National Institutes of Health, Centers for Disease...

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to LGC Genomics LLC for $8,361.40 on April 1, 2015. Work is performed in Bethesda, Maryland. The order was issued with no set-aside designation and carries a firm fixed-price structure. Ultimate completion is scheduled for April 10, 2015.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Regenstrief Institute Inc. for $9,844.90 on September 2, 2016, with ultimate completion on September 25, 2017. The order covers content development for expiring lines and carries firm fixed-price pricing with no set-aside. Place of performance is Bethesda, Maryland.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to LGC Genomics LLC for $8,890.00 on May 28, 2014, with completion due June 2, 2014. The order is firm fixed price with no set-aside designation. Work is performed in Beverly, Massachusetts. The source does not specify the goods or services being procured.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a purchase order to Frontage Laboratories, Inc. for $222,500 on July 21, 2026, under a Total Small Business set-aside. Work is performed in Exton, Pennsylvania. The order is firm fixed price with an ultimate completion date of July 20, 2027.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Cosmo Bio USA Inc. for $32,936.00 on August 22, 2019. Work is performed in Carlsbad, California. The order is priced on a firm fixed price basis with an ultimate completion date of February 24, 2020. The originating pre-solicitation opportunity was posted July 28, 2019 with an August 6, 2019 due date.</p>

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), awarded a $234,964.27 firm-fixed-price purchase order to Government Scientific Source Inc., a small business, to provide a bundled set of 10x Genomics reagents and an instrument upgrade for single-cell and spatial transcriptomics research projects. The contract includes Single-cell RNA-seq reagents, Single-cell RNA + TCR-seq kits, spatial transcriptomics reagents, and an...